Health Condition 1: M468- Other specified inflammatory spondylopathies Health Condition 2: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Conditions
Interventions
Intervention1: Lignocaine 2% + corticosteroid: Intraarticular injections of Lignocaine + corticosteroid
Lignocaine 2% 5 ml into large joints (shoulder and knee) and 2 ml into medium joints (ankle and elbow)
Control Intervention1: Corticosteroid Alone: Intraarticular Corticosteroid (No added Lignocaine)
Sponsors
Department of Internal MEdicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed as a case of rheumatoid arthritis or spondyloarthritis 2. Having bilateral symmetrical swollen joints - either both shoulders or knees or ankles or elbows planned for joint injections
Exclusion criteria
Exclusion criteria: 1. Patient refusal to participate in study 2. Allergy to Lignocaine or Methyl-Prednisolone acetate 3. Joints are damaged 4. Inability of the patient to be able to understand or give pain scores 5. Non-symmetrical joint involvement (Symmetry as assessed by physician) 6. Standard exclusion for any intra-articular steroids including Septic-arthritis or overlying skin infection,Coagulopathy, Joint Prosthesis, Intra-articular fracture
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in joint-painTimepoint: 1-hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Joint-pain at 1-day between the IAC+LA versus IAC aloneTimepoint: 1 day;Improvement in Joint-pain at 1-week between the IAC+LA versus IAC aloneTimepoint: 1 week;Procedural pain between the IAC+LA versus IAC aloneTimepoint: immediate;Relapse rates at 3 months post intra articular injectionTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactRaveesh Bamigatti
PGIMER, Chandigarh
Outcome results
None listed